Schmertzler Michael's most recent trade in Hamilton Lane Inc - Ordinary Shares - Class A was a trade of 100,000 Class B Common Stock done at an average price of $0.0 . Disclosure was reported to the exchange on Feb. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 625,005 | - | 0.0 | 100 | Class B Common Stock |
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 625,005 | - | - | Class B Units | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 17,600 | 17,600 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,000 | 131,266 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Schmertzler Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 8,000 | 123,266 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 08 Jan 2024 | 1,500 | 115,266 (0%) | 0% | 27.8 | 41,715 | Common Stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Sale of securities on an exchange or to another person at price $ 44.86 per share. | 07 Jun 2023 | 1,000 | 116,766 (0%) | 0% | 44.9 | 44,860 | Common Stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,000 | 117,766 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 24,000 | 24,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 6,400 | 109,766 (0%) | 0% | 0 | Common Stock | |
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Mar 2021 | 27,000 | 725,005 | - | - | Class B Units | |
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Mar 2021 | 27,000 | 725,005 | - | 0.0 | 27 | Class B Common Stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 20,000 | 20,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 3,300 | 103,366 (0%) | 0% | 0 | Common Stock | |
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Sep 2020 | 50,000 | 752,005 | - | - | Class B Units | |
| Hamilton Lane Inc - Ordina... | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Sep 2020 | 50,000 | 752,005 | - | 0.0 | 50 | Class B Common Stock |